CBT4CBT for Office Based Buprenorphine

• Status: Recruiting
• Trial end date: 2022-01-30
• Target enrollment: 0
• Participant gender: All

Summary

In this Phase II SBIR/STTR project, our Specific Aim will be to determine if the use of CBT4CBT-Buprenorphine leads to clinically significant improved outcomes and increased retention for buprenorphine maintenance patients in a larger and diverse population of individuals seeking buprenorphine treatment in primary care (N=100).

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: CBT4CBT, LLC
• Treatments: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Naloxone

Criteria

Inclusion Criteria:

• Meets current Diagnostic Statistical Manual (DSM-5) criteria for opioid use disorder

• Requesting buprenorphine maintenance treatment at Central Medical Unit of the APT Foundation

Exclusion Criteria:

• Unstabilized psychotic disorder

• Currently suicidal or homicidal

• Current cocaine, benzodiazepine, or alcohol use disorder.

• Any history of PCP (phencyclidine) use.

• Pregnant or lactating

• Any other physical or mental condition that would contraindicate office-based buprenorphine maintenance treatment.